Found 10 matching trials
Pramipexole Conversion to Ropinirole Controlled Release (CR) PHASE3 A conversion study of Mirapex (pramipexole) to Requip (ropinirole) controll...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
A Study Conducted in Healthy Subjects to Demonstrate Bioequivalence Between Ropinirole Prolonged Release Tablets Manufactured at Crawley and Aranda PHASE1 This is an open-label, randomised, two-period crossover, single dose study ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects PHASE1 The purpose of this study is to investigate the pharmacokinetic profile of ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease PHASE4 This study is a fixed dose, dose response study to characterize the dose re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease PHASE3 To investigate the efficacy and the safety of ropinirole PR/XR tablets to r...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole PHASE2 This study in PD patients is designed to assess the affect food has on the ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) PHASE2 This study was designed to evaluate the pharmacokinetic profile, safety and...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's PHASE3 This study was designed to compare the effectiveness and tolerability of a ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease PHASE4 This is a double blind, fixed dose, parallel group study to characterize th...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily PHASE4 1. In order to compare the benefit, side effects, and patient preference of...
Show More Location
Seoul National University Hospital
Learn More & Join Trial